Acro Biomedical Co (ROCO:6748) FCF Margin %: -94.06% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6748 Acro Biomedical Co Ltd ROCO:6748
66 GF Score
Price NT$295.50
GF Value NT$32.13
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Acro Biomedical Co FCF Margin %?

Acro Biomedical Co ROCO:6748 +16.57% 66 FCF Margin % is -94.06% as of Dec. 2025. GuruFocus rates ROCO:6748 with a GF Score™ of 66/100 and a GF Value™ of NT$32.13 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 950 Biotechnology companies, Acro Biomedical Co ranks worse than 58.42% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Acro Biomedical Co's Free Cash Flow for the six months ended in Dec. 2025 was NT$-23.46 Mil. Acro Biomedical Co's Revenue for the six months ended in Dec. 2025 was NT$24.94 Mil. Therefore, Acro Biomedical Co's FCF Margin % for the quarter that ended in Dec. 2025 was -94.06%.

As of today, Acro Biomedical Co's current FCF Yield % is -0.31%.

The historical rank and industry rank for Acro Biomedical Co's FCF Margin % or its related term are showing as below:

ROCO:6748' s FCF Margin % Range Over the Past 10 Years
Min: -745.37   Med: -187.22   Max: -138.52
Current: -164.59

During the past 8 years, the highest FCF Margin % of Acro Biomedical Co was -138.52%. The lowest was -745.37%. And the median was -187.22%.

ROCO:6748's FCF Margin % is ranked worse than
58.42% of 950 companies
in the Biotechnology industry
Industry Median: -81.28 vs ROCO:6748: -164.59

Acro Biomedical Co FCF Margin % Related Terms

Acro Biomedical Co FCF Margin % Historical Data

* Premium members only.

The historical data trend for Acro Biomedical Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acro Biomedical Co FCF Margin % Chart

Acro Biomedical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial -234.25 -179.46 -138.52 -167.32 -164.59

Acro Biomedical Co Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -104.10 -209.47 -129.05 -296.70 -94.06

ROCO:6748 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Acro Biomedical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acro Biomedical Co FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acro Biomedical Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Acro Biomedical Co's FCF Margin % falls into.


ROCO:6748
66GF Score
Acro Biomedical Co Ltd ROCO:6748
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acro Biomedical Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Acro Biomedical Co's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-62.963/38.255
=-164.59 %

Acro Biomedical Co's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-23.458/24.94
=-94.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -94.06% mean?
Acro Biomedical Co (ROCO:6748) has a FCF Margin % of -94.06% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Acro Biomedical Co and its competitors. According to the industry distribution chart, Acro Biomedical Co ranks #555 out of 950 companies in the Biotechnology industry, placing it in the top 58.4%.
Is Acro Biomedical Co's FCF Margin % too high?
Acro Biomedical Co's current FCF Margin % is -94.06%. Based on the distribution chart, Acro Biomedical Co ranks #555 out of 950 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Acro Biomedical Co has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Acro Biomedical Co's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Acro Biomedical Co ranks #555 out of 950 companies for FCF Margin %. This places Acro Biomedical Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Acro Biomedical Co and its competitors. Acro Biomedical Co's current FCF Margin % is -94.06%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acro Biomedical Co stock overvalued right now?
Based on GuruFocus' analysis, Acro Biomedical Co (ROCO:6748) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$32.13, compared to a current price of NT$295.50 — trading 819.7% above its estimated fair value. The current FCF Margin % is -94.06%. Acro Biomedical Co's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Acro Biomedical Co (ROCO:6748), the current FCF Margin % is -94.06% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Acro Biomedical Co (ROCO:6748) Overvalued in 2026?

Based on GuruFocus' analysis, Acro Biomedical Co stock appears to be overvalued. The current stock price of NT$295.50 is trading 819.7% above its estimated GF Value™ of NT$32.13. GuruFocus considers Acro Biomedical Co to be Significantly Overvalued.

Key valuation signals for ROCO:6748:

  • FCF Margin %: -94.06%
  • GF Value™: NT$32.13 vs. price of NT$295.50 (819.7% above fair value)
  • GF Score™: 66/100 with 6 warning signs

No single metric tells the full story. See the ROCO:6748 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Acro Biomedical Co Business Description

Address 3rd Floor, No. 57, Luke 2nd Road, Luzhu District, Kaohsiung, TWN
Acro Biomedical Co Ltd is a company whose technical team integrates the Research and development capabilities of Taiwan's major scientific research units and medical centers to jointly develop equipment for repairing organs and tissues in various parts of the human body. It mainly focuses on orthopedics, dentistry, cardiovascular specialists, ophthalmology, surgery, wound care, Medical equipment used in sports injuries and other specialties.
66GF Score

Get the complete analysis for ROCO:6748

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$295.50
Price
NT$32.13
GF Value